Australia approves swine flu vaccine; trials in pregnant women in US
This article was originally published in SRA
Executive Summary
Pharmaceutical companies around the world are making progress in tackling the 2009 H1N1 influenza (swine flu) virus. Australia’s Therapeutic Goods Administration is the latest regulatory authority to grant approval to an H1N1 vaccine1,2. Approval was granted using the so-called progressive assessment process, whereby the TGA analysed data on a rolling basis as they became available.